MEDISPA.PRO
Ministry of Health code: A18.05.019 Axis M6 · Immunity and systemic inflammation CEBM: Level C (Device-based phototherapy and haemomodulation)

Intravenous laser blood irradiation (ILBI-365 / ILBI-635)

Intravenous Laser Blood Irradiation (ILBI / VLOK)

Industry clinical and economic procedure passport. Full biological mechanism (MoA), patient preparation protocol, first-choice equipment fleet, integration into the resort's master treatment rooms and market price benchmarks.

To the procedure catalogue Equipment fleet Integration treatment rooms Rates and economics
Session duration
30 min
Turnover: ~45 min
Recommended course
10 sessions
daily or every other day (7–10 sessions)
Throughput capacity
11 pts
per 8-hour shift
Median rate
3 900 ₽
3 000 ₽ – 6 400 ₽
Course cost
39 000 ₽
at market median
Publication volume
Level C
6 publ. in PubMed

Clinical profile

Irradiation of the blood with a low-level laser via a light guide in a vein (or transcutaneously) is a systemic form of photobiomodulation. Small RCTs show reductions in pain and in markers of inflammation and oxidative stress; there are no large studies or uniform dosing parameters.

Every statement links to a publication in the list below. This is a snapshot of published research, not a final assessment of the method: international practice and integrated protocols often run ahead of official publications. Draft based on published research; requires review by a physician. Revision: 2026-10-17.

Mechanism of action

  • Modulation of oxidative stress, inflammation and mitochondrial function is proposed (systemic photobiomodulation). [1]
  • In animal and human studies: increase in anti-inflammatory and decrease in pro-inflammatory cytokines, increase in nitric oxide. [3]
  • Improved blood rheology and red-cell oxygen-transport function and immune regulation have been described. [2]

Where studies show an effect

  • Review of 8 RCTs (340 participants): 30–55 % reduction in pain, IL-6, TNF-α and oxidative stress markers; improved quality of life in cardiovascular disease, diabetic neuropathy, osteoarthritis and other conditions. [1]
  • Clinical data on benefit in musculoskeletal pain, sleep disorders, lung diseases and cognitive impairment after long COVID. [2, 5]
  • Acute kidney injury: in a small RCT the NGAL marker fell faster than with sham treatment. [6]

Open questions and study limitations

  • Small samples, no large RCTs, dosing parameters not standardised. [2, 1]
  • In dentistry the quality of evidence is very low; the effect of the modified technique has not yet been established. [4]
  • There are almost no randomised controlled trials in lung diseases. [5]

Safety

  • No serious adverse events were reported in the review of RCTs. [1]

Protocol in studies

  • Studies used low-level lasers at 660–808 nm; the techniques differed in the type of emission. [3]
Contraindications. Contraindications are determined by a doctor according to the laser device instructions; they are not given in study abstracts.

Equipment fleet and fit-out

Certified first-choice medical equipment and compatible device systems

Equipment registry
Base configuration (Hero Device)
Matrix-VLOK therapeutic laser device + KIVL-01 disposable light guides

Device platform with proven validation of the biological response. Includes built-in biofeedback sensor systems, patient protection protocols and precision dosing of exposure.

Certification: Russian Ministry of Health registration certificate / CE Medical Device Directive Class IIa/IIb.
Compatible platforms in the MEDISPA.PRO registry
"Matrix-VLOK" therapeutic laser device + KL-VLOK-365-2 continuous-wave laser head + UVBI
Medical device, Roszdravnadzor registration certificate / CE
In the registry →

Architectural integration and treatment rooms

Resort rooms housing the treatment station (with SanPiN norms and MEP loads)

All treatment rooms →
1.3.1 120.0 m² · Class B

Treatment room for intravenous infusions / treatment room / laser blood irradiation / ozone therapy room / blood UV irradiation (10 individual cubicles)

General therapeutic interventions and high-tech therapy · Equipment: 11 538 900 ₽

Treatment room passport →

Unit economics and resort price benchmarks

Market analysis based on a sample of premium sanatoriums, wellness hotels and preventive medicine clinics

Market price corridor
25th percentile (P25) 3 000 ₽
Market median 3 900 ₽
75th percentile (P75) 6 400 ₽

Median of prices in industry facilities' price lists, 2026

Basis of the price benchmark

Prices for this procedure appear in the price lists of 5 industry facilities; the median and interquartile range across facilities are shown (each facility counts once).

Evidence base

There are systematic reviews, but they are based on small, heterogeneous RCTs without a standardised dose; there are no large studies.

Publication level C · Little data
  1. 1.
    The clinical efficacy of intravascular laser irradiation of blood (ILIB): A narrative review of randomized controlled trial.
    Photodiagnosis Photodyn Ther, 2025 · Review of RCTs · PMID 40324571
    8 RCTs, 340 participants: consistent reduction in pain, cytokines and oxidative stress, improved quality of life; no serious adverse events.
  2. 2.
    Clinical applications and molecular mechanisms for intravenous laser blood irradiation: a systematic review.
    Lasers Med Sci, 2025 · Systematic review · PMID 41065846
    Positive effects in pain, sleep disorders, lung diseases and long COVID; samples are small and doses are not standardised.
  3. 3.
    Influence of Intravascular Laser Irradiation of Blood (ILIB) on inflammatory cytokines and nitric oxide in vivo: a systematic review.
    Lasers Med Sci, 2024 · Systematic review · PMID 38433159
    6 studies: increase in anti-inflammatory cytokines and nitric oxide, decrease in pro-inflammatory cytokines.
  4. 4.
    Effect of modified intravascular laser irradiation of blood in the oral and systemic conditions during dental treatment-A systematic review.
    Lasers Med Sci, 2024 · Systematic review · PMID 39704836
    Modified technique in dentistry: very low quality of evidence; further studies are needed.
  5. 5.
    Intravascular laser irradiation of blood (ILIB) used to treat lung diseases: a short critical review.
    Lasers Med Sci, 2023 · Critical review · PMID 36964849
    In lung diseases the results are encouraging, but randomised studies are insufficient.
  6. 6.
    Intravenous Laser Therapy in Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    J Lasers Med Sci, 2021 · RCT · PMID 34733772
    Acute kidney injury, 26 patients: NGAL fell faster than with sham treatment.

Publications were found in PubMed; titles and journals are given verbatim, conclusions are a brief summary of the abstracts under the conditions of the specific studies. The level shows the volume of published data, not the value of the method: A — Plenty of data: consistent systematic reviews and meta-analyses of RCTs; B — Some data: reviews or several RCTs, results are heterogeneous; C — Little data: single RCTs or controlled studies; D — Scarce data: mainly reviews, observational and experimental studies. The passport is updated as new work is published and with regard to international practice.